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Abstract
Background: The contribution of vitamin D to thyroid disorders has received paramount attention; however, results
are mixed. Hence, we designed a systematic review and meta-analysis to obtain a definitive conclusion.
Methods: The search included PubMed, ISI Web of Science, Scopus, and Google Scholar databases up to March
2021 to collect available papers reporting the relationship between serum levels of vitamin D and thyroid disorders.
The pooled effect was reported as weighted mean difference (WMD) and 95% confidence interval (CI).
Results: Out of 6123 datasets, 42 were eligible to get into this systematic review and meta-analysis. Serum vitamin
D was markedly lower in autoimmune thyroid diseases (AITD) (WMD − 3.1 ng/dl; 95% CI, − 5.57 to − 0.66; P = 0.013;
I2 = 99.9%), Hashimoto’s thyroiditis (HT) (WMD − 6.05 ng/dl; 95% CI, − 8.35 to − 3.75; P < 0.001; I2 = 91.0%) and
hypothyroidism patients (WMD − 13.43 ng/dl; 95% CI, − 26.04 to − 0.81; P = 0.03; I2 = 99.5%), but not in subjects
with Graves’ disease (GD) (WMD − 4.14 ng/dl; 95% CI, − 8.46 to 0.17; P = 0.06; I2 = 97.5%).
Conclusions: Our findings suggested lower vitamin D levels in patients with hypothyroidism, AITD, and HT
compared to healthy subjects. However, the link between serum vitamin D and GD was only significant among
subjects ≥40 years old.
Keywords: Vitamin D, Thyroid disorders, Systematic review, meta-analysis
Background
Vitamin D is an essential fat-soluble nutrient with
hormone-like activity [1, 2]. Vitamin D deficiency is
among the most common health problems in the world
in all age groups, even in low latitude countries with suf-
ficient UV radiation or industrialized countries with a
long history of vitamin D fortification strategies. Previ-
ous studies have indicated that about one billion people
around the world have been diagnosed with vitamin D
deficiency [3]. Recent evidence has shown the prevalence
of vitamin D deficiency in both developed and
developing countries, which in Europe is 13% and in the
United States 19% [4–6]. Vitamin D deficiency has in-
creased in recent years in Iran, and reports have revealed
that the vitamin D deficiency rate is nearly 50% [2]. Risk
factors for vitamin D deficiency include aging, female
sex, winter season, obesity, malnutrition, lack of sun ex-
posure, and dark skin pigmentation [7]. Accordingly,
sufficient attention to vitamin D deficiency diagnosis is
needed for treatment to decrease its undesirable effects
on human health.
Over the last decades, numerous studies have indi-
cated that low serum vitamin D levels are associated
with a series of diseases such as high blood pressure,
heart disease, diabetes, cancer, mood disorders, multiple
sclerosis, and autoimmune diseases [8, 9]. This vitamin
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exerts its biological actions through nuclear vitamin D
receptors (VDR) that reside in most human cells and tis-
sues [10]. Hence, vitamin D plays its role through the
regulation of gene expression in places where its recep-
tors exist, such as the endocrine system [11].
The thyroid gland is one of the largest endocrine
glands with many roles for homeostatic control, includ-
ing growth, energy expenditure, and metabolism [12,
13]. Any thyroid disorder could result in a cluster of
metabolic ailments [12–14]. Recent literature has illus-
trated the presumed association between serum vitamin
D and thyroid diseases [15]. This association results
from the presence of similar receptors for vitamin D and
thyroid hormones, named steroid or nuclear hormone
receptors. These shreds of evidence show the import-
ance of the role of vitamin D in thyroid function and the
association between vitamin D deficiency and thyroid
diseases. However, some studies observed no significant
relationship [16–18]. Therefore, we conducted a system-
atic review and meta-analysis to survey all observational
studies regarding the association between serum vitamin
D levels and thyroid disorders, including
hypothyroidism, autoimmune thyroid disease (AITD),
Hashimoto’s thyroiditis (HT), and Graves’ disease (GD)
among the adult population.
Methods
After registration on the Prospero database
(CRD42020187237), this dataset was conceived pursuant
to the Preferred Reporting Items for Systematic Reviews
and Meta-analysis (PRISMA) statement [19].
Search strategy
We performed a systematic literature search up to
March 2021 in four databases, including PubMed, ISI
Web of Science, Scopus, and Google Scholar to find pa-
pers reporting the relationship between serum levels of
vitamin D and thyroid disorders. The terms used for the
database search were “vitamin D” OR “25-hydroxyvita-
min D” OR “1,25-dihydroxyvitamin D” OR “cholecalcif-
erol” OR “ergocalciferol” OR “calcitriol” OR “vitamin
D3” AND “hypothyroidism” OR “hypothyroid” OR “thy-
roid disorder” OR “triiodothyronine” OR “thyroxin” OR
“thyroid stimulating hormone” OR “thyroid hormones”
OR “hyperthyroidism” OR “hyperthyroid” OR “auto-
immune thyroiditis” OR “anti-thyroid peroxidase” OR
“Graves’, disease”, OR “Hashimotoʼs thyroiditis”. The au-
thors also screened the reference sections of the con-
tained articles to spot any other eligible studies not
captured via the online database search.
Study selection
Before the screening process, all search results were
exported into the EndNote X7 software (Thomson
Corporation, Stamford, USA). Original observational hu-
man studies (case-control or cross-sectional) about the as-
sociation between serum vitamin D and thyroid disorders
with reported means, medians, or odds ratios (ORs), and
the corresponding 95% confidence intervals (CIs) were in-
cluded. Studies that recruited women during pregnancy or
lactation, non-human datasets, reviews, case reports, edi-
torials, poster abstracts, non-original, or irrelevant datasets
were excluded. Two investigators were responsible for the
selection process to lower the potential error (S. T & A.
A). The difference of opinion was dealt with the cooper-
ation of a third reviewer (G. A).
Data extraction
The data of interest were extracted from each study
using a predefined excel form in a duplicate and blinded
manner. For each study, the extracted information was
as follows: first author’s name, publication year, location,
sample size, sex, age, body mass index (BMI), study de-
sign, vitamin D assay method, the season of sample col-
lection, and population health status. Two independent
reviewers conducted the processes of data extraction (S.
T & A. A). The difference of opinion on a given study
was dealt with via discussion, and if necessary, arbitra-
tion by a third reviewer (G. A).
Study quality assessment
According to the Newcastle-Ottawa Quality Assessment
Scale for observational studies [20], authors assessed the
quality of the included studies on three domains: selec-
tion (5 points), comparability (2 points), and outcome (3
points). Scores of 7–10, 5–6, and 0–4 indicate high,
moderate, and low-quality studies, respectively [21].
Statistical analysis
Authors run a meta-analysis, including weighted mean
difference (WMD) with 95% CIs plus a random effect
model, to estimate the quantitative summary of the asso-
ciation between vitamin D and thyroid disorders, includ-
ing hypothyroidism, AITD, HT, and GD. Mean ±
standard deviation (SD) was extracted to estimate the
pooled effects using WMD. For datasets with a standard
error (SE), SD was determined using the following equa-
tion: SE × √n. Related equations were used to obtain the
preferred data out of the median ± range or interquartile
range [22]. If a study presented analyses stratified by cer-
tain key variables such as participants’ health status,
stratified estimates were assumed to be independent of
each other and included as a separate unit of observation
in the meta-analysis. To assess the influence of each
study on the stability of the meta-analysis results, the au-
thors carried out a sensitivity analysis. Moreover, sub-
group analysis based on age, gender, geographical
population, study design, and population health status
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was executed whenever it was possible. STATA software,
version 11.2 (Stata Corp, College Station, TX, USA) was
used for data analysis with P-values < 0.05 considered as
statistically significant. Heterogeneity was checked using
the I2 index. I2 index equal to 25, 50, or 75% represents
low, moderate, and high heterogeneity, respectively [23].
The funnel plots were visually inspected to detect any
publication bias, and Egger’s and Begg’s tests defined the
extent of funnel plot asymmetry [24].
Results
Search results
Our initial search through databases identified a total of
6123 papers. With duplicates removed, the 3062
remaining articles were examined based on the review of
the titles and abstracts by two independent reviewers.
Authors retrieved and reviewed 98 articles based on the
full text, and finally, 35 studies were eligible to get into
the current study. Moreover, the works of Bouillon et al.
[25], Unal et al. [26], Ma et al. [27], Ke et al. [28], Fawzy
et al. [29], Toulis et al. [30], and Komisarenko et al. [31]
were divided into two different studies. Therefore, a total
of 42 eligible studies were included in the meta-analysis.
The PRISMA flowchart briefly states the results of the
study selection process (Fig. 1).
Overview of included studies
A total of 35 studies (42 arms), including 28 case-
control [17, 25–51] and 7 cross-sectional studies [52–
58] with sample sizes varying from 38 to 6685 subjects
were included in our systematic review. The selected
studies were published between 1980 and 2018. Among
these, 9 studies were from Turkey [26, 34, 36, 37, 39, 42,
Fig. 1 The flow diagram of study selection
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Table 1 Characteristics of included studies




























Belgium 77/27 39 – Case-
control
GD RIA – Moderate
Camurdan et al.,
2012
Turkey 126/26 12.05 – Case-
control
HT HPLC – Low







India 124/36 36.37 22.05 Case-
control
GD RIA All season Moderate
Chailurkit et al.,
2012
Thailand 1292/1290 55 23.3 Cross-
sectional
AITD HPLC All season High
Bozkurt et. al.,
2013
Turkey 369/ 171 42.5 28.4 Case-
control





















Fawzy et al., 2013
(a)




CLIA All season Low
Fawzy et al., 2013
(b)




CLIA All season Low





Unal et al., 2014
(a)
Turkey 378 F&M 44.6 – Case-
control
HT CLIA – Low
Unal et al., 2014
(b)
Turkey 151 F&M 44.6 – Case-
control
GD CLIA – Low
Demir et al., 2014 Turkey 24/14 12.95 – Case-
control
AITD – – Moderate
Zhang et al., 2014 China 84/56 32.34 20.57 Case -
control
GD ELISA Summer, autumn Moderate
Shin et al., 2014 Korea 267/37 49.9 – Cross
sectional
AITD RIA All season High
Choi et al., 2014 Korea 2793/3892 54.1 24.2 Cross-
sectional
AITD RIA All season Moderate
Evliyaoglu et al.,
2015
Turkey 117/52 12.08 – Case-
control
HT HPLC Winter, spring,
summer
Moderate
Ma et al., 2015 (a) China 100/ 40 41.05 28.18 Case-
control
HT ECLA Autumn, winter,
spring
Moderate
Ma et al., 2015 (b) China 97/43 41.01 28.18 Case-
control





Poland 84/10 47.62 – Case-
control
HT ELISA Spring Moderate
Toulis et al., 2015
(a)
Greece 264 F&M 67.6 31.6 Case -
control
AITD+T2DM RIA Winter, spring Moderate
Toulis et al., 2015
(b)




RIA Winter, spring Moderate
Muscogiuri et al.,
2015
Italy 50 F 26.8 28.1 Cross-
sectional
AITD+PCOS CLIA Spring, summer High
Metwalley et al.,
2015
Egypt 88/24 14.32 18.8 Case-
control
AITD HPLC – Moderate
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43, 48, 49], 3 each from Saudi Arabia [17, 32, 35], Poland
[38, 52, 59], China [27, 28, 51] and Korea [54, 55, 58], 2
each from Egypt [50, 60] and Italy [40, 57] and one each
from Belgium [25], Canada [33], Brazil [44], Japan [47],
India [45], Sweden [46], Thailand [53], Greece, United
States [56], and Ukraine [31]. Among the 35 studies, 29
recruited both genders [25, 27–32, 34–41, 43–46, 48–56,
58], 4 only women [17, 42, 47, 57], and 2 studies did not
report the gender [26, 33]. Eighteen studies mentioned
BMI [27, 28, 30, 31, 33, 35, 36, 40, 45, 47, 50–53, 55–58]
and 26 studies pointed to the time of year when samples
were collected [17, 27–30, 32, 33, 36, 38–47, 49, 51, 53–
55, 58, 61, 62]. All the included studies assessed the
serum levels of 25(OH) D and none of them examined
the dietary intake of vitamin D in participants. Addition-
ally, among the selected studies, 6 [52–54, 56–58] were
considered as high quality and the rest [17, 25–51, 55]
had moderate quality. Table 1 gives an outline of the
characteristics of the included studies.
Findings from the meta-analysis
Serum 25(OH) D and AITD
Thirteen datasets comprising 12,916 participants,
inspected the association between serum levels of
25(OH) D and AITD status among 1886 AITD diag-
nosed and 11,030 non-AITD individuals [30, 31, 48–50,
53–56, 58, 62]. Vitamin D was significantly associated
with AITD status (WMD − 3.1 ng/dl; 95% CI, − 5.57 to
− 0.66; P = 0.013) with significant heterogeneity (I2 =
99.9%, P < 0.001) (Fig. 2). In other words, patients with
AITD showed significantly lower serum vitamin D levels
compared to non-AITD subjects. In the metabolic
Table 1 Characteristics of included studies (Continued)



















Zhou et al., 2015 USA 1076/930 37.8 26.68 Cross-
sectional
AITD – – High
Sonmezgoz et al.,
2016
Turkey 76/68 11.12 – Case-
control
HT CLIA Autumn Moderate
Kim, 2016 Korea 641/135 45.25 23.6 Cross-
sectional
AITD ECLIA All season High
Giovinazzo et al,
2016
Italy 175/25 41 26.5 Case-
control





Turkey 453 F 40.3 – Case-
control
HT ECLA Spring, summer,
autumn
Moderate
Musa et al., 2017 Saudi
Arabia







Ke et al., 2017 (a) China 65/47 38.68 22.57 Case-
control
HT ECLA Autumn, winter Moderate
Ke et al., 2017 (b) China 61/41 38.13 22.42 Case-
control
GD ECLA Autumn, winter Moderate
Lawnicka et al.,
2017
Poland 56/15 54.4 – Case-
control
HT CLIA Winter, spring Moderate
Planck et al., 2017 Sweden 1167/1430 52.45 – Case-
control
GD – All season Moderate
Mirhosseini et al.,
2017




HPLC All season Moderate
Akdere G et al.,
2018
Turkey 66/94 28.3 – Case-
control
AITD+T1DM ELISA All season Moderate







Ukraine 29/21 39.5 31.25 Case-
control
AITD+T1DM ELISA – Moderate
Komisarenko &
Bobryk, 2018 (b)
Ukraine 31/19 57.25 37.25 Case-
control
AITD+ T2DM ELISA – Moderate
Botelho et al.,
2018
Brazil 143/15 46.8 – Case-
control
HT CLIA Spring, summer Low
F: Female, M: Male, BMI: Body Mass Index, RIA: Radio Immunoassay, CLIA: Chemiluminescence Immunoassay, HPLC: High Performance Liquid Chromatography,
ALL: All seasons of the year, ELISA: Enzyme-Linked Immunosorbent Assay, HT: Hashimoto’s Thyroiditis, ECLA: Euglobulin Clot Lysis Assay, GD: Graves’ Disease, AITD:
Autoimmune Thyroid Disease, ECLIA: Electrochemiluminescence Immunoassay, PCOS: Polycystic Ovary Syndrome, T1DM: Type 1 Diabetes Mellitus, T2DM: Type 2
Diabetes Mellitus
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disorders subgroup, vitamin D and AITD were related
(WMD − 3.48 ng/dl; 95% CI, − 6.72 to − 0.24). However,
no significant association between vitamin D and AITD
was observed in the other subgroup (Table 2). Findings
from the sensitivity analysis revealed that the exclusion
of Metwalley et al. study from the analysis (WMD −
2.00 ng/dl; 95% CI, − 4.54 to 0.53) [50] modified the
overall effect. No evidence of publication bias was docu-
mented (Begg’s test: P = 0.714, Egger’s test: P = 0.323).
Serum 25(OH) D and GD
Eight citations addressed the link between serum levels of
25(OH) D and GD status among 604 GD diagnosed and
2827 non-GD individuals [25–28, 45–47, 51]. Overall, meta-
analysis showed that serum vitamin D was not linked to GD
(WMD − 4.14 ng/dl; 95% CI, − 8.46 to 0.17; P= 0.06) and
heterogeneity was significant (I2 = 97.5%, P < 0.001) (Fig. 3).
Subgroup analyses based on age and geographical area
(Table 2) showed a significant association in studies recruit-
ing ≥40 years-old subjects (WMD − 8.79 ng/dl; 95% CI, −
15.87 to − 1.72; I2 = 98.1). Jyotsna et al. study [45] influenced
the meta-analysis results (WMD − 5.04 ng/dl; 95% CI, − 9.62
to − 0.46). Publication bias was not recognized (Begg’s test:
P= 0.805, Egger’s test: P= 0.542).
Serum 25(OH) D and HT
Twelve studies with 2440 participants examined the as-
sociation between 25(OH) D and HT status among 1375
HT diagnosed and 1065 healthy subjects [26–28, 36–
44]. The results of the meta-analysis indicated
significantly lower levels of serum vitamin D among HT
patients compared to healthy ones (WMD − 6.05 ng/dl;
95% CI, − 8.35 to − 3.75; P < 0.001) with significant het-
erogeneity (I2 = 91.0% P < 0.001) (Fig. 4). Subgroup ana-
lyses based on participants’ age and geographical area
investigated the source of heterogeneity (Table 2). Keep-
ing out the individual studies did not alter the overall
meta-analysis results. Publication bias was not detected
(Begg’s test: P = 0.784, Egger’s test: P = 0.175).
Serum 25(OH) D and hypothyroidism
Nine studies examined the relationship between serum
levels of 25(OH) D and hypothyroidism among 372
hypothyroid patients and 802 healthy individuals [17, 25,
29, 32–35, 61]. Vitamin D and hypothyroidism status
were significantly linked (WMD − 13.43 ng/dl; 95% CI,
− 26.04 to − 0.81; P = 0.03); patients with hypothyroidism
presented with lower serum vitamin D compared to
healthy subjects. There was significant heterogeneity
among the included studies (I2 = 99.5%, P < 0.001)
(Fig. 5). Pursuant to subgroup analysis, vitamin D and
hypothyroidism were associated only among studies
recruiting both genders (WMD − 15.43 ng/dl; 95% CI, −
29.49 to − 1.37) and studies that included the non-Asian
population (WMD − 14.31 ng/dl; 95% CI, − 26.53 to −
2.10) (Table 2). Keeping out a number of studies includ-
ing Ucar et al. [34] (WMD − 11.33 ng/dl; 95% CI, −
22.76 to 0.08), Mackawy et al. [32] (WMD − 11.40 ng/dl;
95% CI, − 22.92 to 0.10), Mirhosseini et al. [33] (WMD
− 14.41 ng/dl; 95% CI, − 29.01 to 0.18), Fawzy et al.
Fig. 2 The association between the serum 25(OH) D level and AITD
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(a) [29] (WMD − 11.98 ng/dl; 95% CI, − 24.84 to 0.86) and
Fawzy et al. (b) [29] (WMD − 11.10 ng/dl; 95% CI, − 22.33
to 0.13) modified the overall effect. Due to evidence of
publication bias (Begg’s test: P = 0.835, Egger’s test: P =
0.006), possible un-detected studies were tracked by trim
and fill analysis, but this method could not add any dataset
to our included ones.
Discussion
As far as we know, this is the first comprehensive at-
tempt to examine the association between serum levels
of vitamin D and thyroid disorders in form of a system-
atic review and meta-analysis. It revealed that vitamin D
was significantly associated with hypothyroidism, AITD,
and HT. Furthermore, vitamin D was significantly lower
among ≥40-year-old GD subjects. Some issues should be
considered when elucidating the results. First of all,
there were substantial inter-assay differences in the per-
formance of commercially available kits for serum vita-
min D assay [63]. This notion may impact the results
and play a considerable role as a heterogeneity factor.
Also, seasonal variation in serum vitamin D should be
Table 2 Subgroup analysis to assess the association between serum levels of vitamin D and thyroid disorders












Adult 9 −5.69 −8.20, −3.18 89.6 <0.001
Adolescent 3 −6.81 −11.70, −1.93 87.8 <0.001
Geographical population 0.05
Turkey 6 −6.95 −11.15, −2.75 91.2 <0.001
Other countries 6 −5.35 −9.13, −1.58 92 <0.001
Hypothyroid
Gender 0.057
Both sex 8 −15.43 −29.49, −1.37 99.6 <0.001
Female 1 2.60 −1.38, 6.58 – –
Geographical population <0.001
Asian 4 −12.34 −31.89, 7.20 99.3 <0.001





Asian 6 −1.74 −3.95, 0.46 80.2 <0.001
Non-Asian 2 −7.10 −18.47, 4.25 99.3 <0.001
Participants age <0.001
≥ 40 years old 4 −8.79 −15.87, −1.72 98.1 <0.001
< 40 years old 4 −0.54 −2.07, 0.98 54.3 0.08
AITD
Geographical population <0.001
Asian 6 −2.08 −5.6, 1.43 100 <0.001
Non-Asian 7 −4.13 −8.31, 0.05 93.9 <0.001
Study design <0.001
Case control 7 −3.65 −7.75, 0.44 94.4 <0.001
Cross-sectional 6 −2.52 −6.10, 1.04 100 <0.001
Participants health status <0.001
With metabolic disorders 5 −3.48 − 6.72, −0.24 85.9 <0.001
Without metabolic
disorders
8 −2.87 −5.97, 0.23 99.9 <0.001
1Calculated by Random-effects model
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kept in mind when interpreting the results [64]. This
fact has been excused in some papers [25, 26, 31, 34, 35,
37, 46, 48, 50, 56]. Inconsistencies in terms of the season
of sample collection could also influence our final re-
sults. Besides, it has been proven that the bioavailability
of vitamin D diminishes among overweight/obese indi-
viduals [65]; however, most of the included articles
disregarded BMI as a confounding factor and probable
source of heterogeneity [17, 18, 25, 26, 29, 32, 34, 37–39,
41–44, 46, 48, 49, 54].
Pursuant to previous reports, the role of vitamin D in
immunity is through producing anti-inflammatory and
immune-regulatory markers via VDR expression in the
nucleus of cells [66]. VDR is involved in cellular
Fig. 3 The association between the serum 25(OH) D level and GD
Fig. 4 The association between the serum 25(OH) D level and HT
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immunity function by stimulating innate and adaptive
immune responses [66]. Polymorphisms of the VDR are
related to the predisposition of people to thyroid disor-
ders such as hypothyroidism [12, 67]. VDR modulates
the effects of vitamin D as its specific and intracellular
receptor. Polymorphisms of the VDR gene may decrease
vitamin D activity [12]. Through a meta-analysis, Wang
et al., reported a significant link between VDR gene
polymorphisms and autoimmune thyroid disorders in di-
verse ethnic groups [66]. Vitamin D has hindering effects
on the production of inflammatory cytokines such as
interleukin (IL)-1, IL-6, IL-8, IL-12, and tumor necrosis
factor (TNF)-α [68, 69]. Also, it suppresses dendritic cell
differentiation and maturation via a reduced expression
of the major histocompatibility complex (MHC) class II
molecules, co-stimulatory molecules, and IL-12 [68, 69].
Additionally, vitamin D makes the induction of T regula-
tory cells simpler to diminish T cell-dependent immune
responses in autoimmune diseases [68, 69]. T and B-
cells reaction to thyroid antigens in genetically-
vulnerable subjects lead to HT [42]. Based on previous
studies, serum levels of 25-OH D3 < 20 ng/mL can ex-
acerbate positive thyroid autoantibodies such as anti-
thyroid peroxidase (TPOAb) and anti-thyroglobulin
(TgAb) [70–72]. Additionally, high serum levels of cal-
cium and phosphorous and low levels of circulating
parathyroid hormone may inhibit renal 25(OH) D1-α
hydroxylase function [17]. Thus, due to lower production
of 1,25 (OH)2 D, serum 24,25 (OH) D and thyroid hormone
levels will be higher [17]. Overall, vitamin D could contribute
to the prevention or correction of hypothyroidism and im-
provement of thyroid function [17].
The limitations of this study are as follows. There was
significant heterogeneity in our study that may have af-
fected the results and diminished the generalizability of
the outcomes. The probable sources of heterogeneity
might be differences in age, gender, BMI, study design,
vitamin D assay methods and kits, the season of sample
collection, geographical variation, and quality of the
studies. Moreover, the nature of cross-sectional studies
makes it impossible to draw a causal link between vari-
ables. Furthermore, there was no information regarding
dietary vitamin D intake that could have affected serum
levels of vitamin D.
Conclusion
In the present systematic review and meta-analysis, vita-
min D levels were significantly lower in hypothyroidism,
AITD, and HT patients compared to healthy people.
However, there was no significant association between
serum vitamin D and GD, except among subjects ≥40
years old. The effect sizes of the included studies showed
significant heterogeneity which might affect the inter-
pretation of results. Further well-designed prospective
cohort studies and clinical trials are needed for a better
understanding of the relationship between vitamin D
and thyroid disorders.
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